Deep learning MRI signature to predict survival and treatment benefit from temozolomide in IDH-wildtype glioblastoma. - Huixia You; Yuanshen Zhao; Qiuchang Sun; Wenxia Wu; Xiaofei Lv; Yinsheng Chen; Huailing Zhang; Zhi-Cheng Li 001 (Displays, 2023)

Riskformer: Survival prediction from MR imaging in patients with IDH-wildtype glioblastoma. - Huixia You; Jiankai Zhang; Yuanshen Zhao; Tong Mo; Diangang Fang; Xiaofei Lv; Zhicheng Li 001; Haifeng Wang 003; Dong Liang 001; Hongwu Zeng; Yinsheng Chen (Displays, 2023)